Brokerages Anticipate Anthem (ANTM) to Post $4.16 EPS

Brokerages expect Anthem (NYSE:ANTM) to announce earnings per share of $4.16 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Anthem’s earnings, with the highest EPS estimate coming in at $4.40 and the lowest estimate coming in at $3.75. Anthem reported earnings of $3.37 per share in the same quarter last year, which would suggest a positive year over year growth rate of 23.4%. The company is scheduled to issue its next earnings report on Wednesday, July 25th.

On average, analysts expect that Anthem will report full-year earnings of $15.38 per share for the current fiscal year, with EPS estimates ranging from $15.30 to $15.42. For the next fiscal year, analysts anticipate that the business will post earnings of $16.85 per share, with EPS estimates ranging from $16.26 to $18.00. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that that provide coverage for Anthem.

Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, April 25th. The company reported $5.41 earnings per share for the quarter, topping analysts’ consensus estimates of $4.83 by $0.58. Anthem had a return on equity of 12.77% and a net margin of 4.60%. The company had revenue of $22.34 billion during the quarter, compared to analysts’ expectations of $22.55 billion. During the same period last year, the firm earned $4.68 EPS. The firm’s revenue for the quarter was up .1% on a year-over-year basis.

A number of analysts have weighed in on ANTM shares. Cowen reaffirmed a “buy” rating and set a $280.00 price objective on shares of Anthem in a research report on Wednesday, January 31st. Cantor Fitzgerald reaffirmed a “buy” rating and set a $275.00 price objective on shares of Anthem in a research report on Friday, January 19th. ValuEngine raised Anthem from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Zacks Investment Research raised Anthem from a “hold” rating to a “buy” rating and set a $252.00 price objective for the company in a research report on Monday, April 9th. Finally, Morgan Stanley increased their price objective on Anthem from $266.00 to $269.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 26th. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $249.00.

In related news, insider Joseph Swedish sold 27,846 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The stock was sold at an average price of $231.12, for a total value of $6,435,767.52. Following the completion of the transaction, the insider now directly owns 84,545 shares of the company’s stock, valued at approximately $19,540,040.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas C. Zielinski sold 20,455 shares of the firm’s stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of $229.23, for a total value of $4,688,899.65. The disclosure for this sale can be found here. Insiders sold a total of 135,264 shares of company stock valued at $30,794,160 over the last three months. Insiders own 0.31% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in Anthem by 2.7% in the 1st quarter. BlackRock Inc. now owns 22,596,529 shares of the company’s stock valued at $4,964,457,000 after purchasing an additional 596,099 shares in the last quarter. Geode Capital Management LLC increased its stake in Anthem by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 2,864,024 shares of the company’s stock valued at $643,146,000 after purchasing an additional 51,003 shares in the last quarter. Viking Global Investors LP increased its stake in Anthem by 190.5% in the 4th quarter. Viking Global Investors LP now owns 2,537,576 shares of the company’s stock valued at $570,980,000 after purchasing an additional 1,664,112 shares in the last quarter. OppenheimerFunds Inc. increased its stake in Anthem by 7.9% in the 1st quarter. OppenheimerFunds Inc. now owns 2,335,287 shares of the company’s stock valued at $513,063,000 after purchasing an additional 171,708 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its stake in Anthem by 31.5% in the 1st quarter. Allianz Asset Management GmbH now owns 2,108,871 shares of the company’s stock valued at $463,319,000 after purchasing an additional 505,252 shares in the last quarter. 88.27% of the stock is owned by hedge funds and other institutional investors.

Anthem traded up $0.08, reaching $231.87, during mid-day trading on Monday, Marketbeat.com reports. 899,921 shares of the company were exchanged, compared to its average volume of 1,716,103. Anthem has a twelve month low of $174.96 and a twelve month high of $267.95. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $59.15 billion, a price-to-earnings ratio of 19.26, a PEG ratio of 1.29 and a beta of 0.87.

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 25th. Stockholders of record on Friday, June 8th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.29%. Anthem’s dividend payout ratio is currently 24.92%.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Get a free copy of the Zacks research report on Anthem (ANTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply